Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Research and Innovation Action · Running

MULTIR MULti-Tumour based prediction and manipulation of Immune Response

Coordinator
Institut National De La Sante Et De La Recherche Medicale, France
Runs
1 January 2024 to 31 December 2027
Status
Running
EU funding
€8.5m
Total cost
€8.5m
Partners
17 organisations in 12 countries
Type
Research and Innovation Action
Grant agreement
101136926

What the project is doing

In the project's own words, from its summary on CORDIS.

Only few patients respond to tumor treatment as desired. Treatment heavily relies on host tumor interactions, including exploiting the host immune response against the tumor. The underlying mechanisms of host tumor interaction are largely unknown, guidance on specific intervention is missing. To improve outcome, better understanding of tumor-host interaction is needed. Large numbers of molecular snapshots will provide increased phenotyping coverage and better represent tumor-host evolution over time.

In an innovative approach, MULTIR aims at investigating not a single tumor entity, but at compiling data from skin, lung and bladder cancer (most drugs target specific molecular features, irrespective of the tumor origin) to identify with high power the critical elements in the tumor-host interaction responsible for therapy response. In a multi-disciplinary approach involving leading clinicians, immunologists, experts in omics, digital technologies, social sciences and patient representatives from 10 EU countries and beyond, and an extensive outreach plan to ensure rapid transfer of MULTIR output to society, MULTIR combines existing multi-layer (epidemiological, genetic, clinical, pathologic, imaging, molecular) data from major studies on these tumors, using AI-based approaches to unveil functional modules regulating tumor-host interactions followed by validation of findings in models and synthetic patients.

Harmonization with major EU initiatives will maximize use of European resources. Impact on all scientific, technological and societal levels is expected, including increased understanding of tumor-host interactions, generation of a unique resource of harmonized data on three major cancer types available to the community in compliance to the legal and ethics framework, boost of drug discovery, and an AI-based predictor for treatment response.

MULTIR outreach plan includes policymakers and regulators, to support prompt assessment and uptake into the health systems. This action is part of the Cancer Mission cluster of projects on “Understanding (tumour-host interactions)”.

Who is involved

OrganisationCityCountryRole
Institut National De La Sante Et De La Recherche MedicaleParisFranceCoordinator
Medizinische Universitaet WienWienAustriaParticipant
Royal Institution for the Advancement of Learning Mcgill UniversityMontrealCanadaAssociatedpartner
Universitat ZurichZurichSwitzerlandAssociatedpartner
Mosaiques Diagnostics GmbHHannoverGermanyParticipant
Universitaetsklinikum EssenEssenGermanyParticipant
Aarhus UniversitetAarhus CDenmarkParticipant
Elliniki Ogkologiki Erevnitiki OmadaAthensGreeceParticipant
Exelixis Diacheirisi Erevnas Kai Epikoinonia EeGerakas AttikiGreeceParticipant
Idryma Iatroviologikon Ereunon Akademias AthinonAthinaGreeceParticipant
Eticas Data SocietySarriaSpainParticipant
Centre Hospitalier Universitaire De NantesNantesFranceParticipant
Sorbonne UniversiteParisFranceParticipant
Atomic Intelligence D.o.o.ZagrebCroatiaParticipant
University College Dublin, National University of Ireland, DublinDublinIrelandParticipant
Stichting Radboud Universitair Medisch CentrumNijmegenNetherlandsParticipant
FolkehelseinstituttetOsloNorwayParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI